United States News All stories

SunCar Technology Group (NASDAQ:SDA) reported an expansion in first-quarter revenue and sustained bottom-line profitability, driven by accelerating consumer demand for electric vehicle insurance and broader commercial partnerships with major digital and automotive brands across China.

Israel Corp. (NASDAQ:NOAP) reported a substantial increase in its first-quarter net profit, driven by expanding returns from its core chemicals subsidiary and an investment windfall stemming from a recent food-technology listing.

Merck (NYSE:MRK) announced that its board of directors has formally declared a quarterly dividend of $0.85 per share.

Kyivstar Group (NASDAQ:KYIV) announced the acquisition of six solar power plants in Ukraine’s Lviv region for a total consideration of UAH 3.6 billion (approximately $80.8 million), accelerating the telecommunication firm’s vertical integration into sovereign power generation to mitigate localized infrastructure risks.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) unveiled new clinical data expanding the medical profile of plozasiran, its approved RNA interference (RNAi) therapeutic, demonstrating that the drug can be administered to patients suffering from moderate-to-severe renal impairment or moderate hepatic impairment without necessitating a reduction in dose.

Shares of Micron Technology (NASDAQ:MU) surged to an all-time intraday high following a dramatic price target increase from UBS, which argued that the artificial intelligence infrastructure buildout has permanently altered the financial predictability and valuation framework of the memory chip industry.

Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) released updated Phase 1/2 clinical data for its experimental antibody-drug conjugate, CRB-701, demonstrating therapeutic activity in patients with pretreated, human papillomavirus (HPV)-associated solid tumors that express high levels of the Nectin-4 protein.

Performance Shipping (NASDAQ:PSHG) reported a 59% increase in first-quarter revenue for 2026, driven by a larger operational fleet and stronger charter rates that accelerated the company's operating cash generation.

Dyne Therapeutics (NASDAQ:DYN) submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration seeking conditional marketing clearance for z-rostudirsen, its investigational treatment targeting a specific subset of patients with Duchenne muscular dystrophy (DMD).

Virax Biolabs Group (NASDAQ:VRAX) announced positive preliminary performance metrics from an early pilot dataset for ViraxImmune™, its proprietary blood-based diagnostic test under development for Long COVID and related post-acute infection syndromes (PAIS).

Uni-Fuels Holdings (NASDAQ:UFG) raised its full-year revenue guidance after reporting sharp top-line expansion and volume growth for the first quarter of 2026, driven by a broad scale-up in global marine fuel trading and commercial market capture.

CSW Industrials (NYSE:CSW) reported record financial results for both the fourth quarter and the full fiscal year of 2026, navigating higher interest expenses and non-cash charges through a combination of aggressive acquisition integration and a return to organic expansion in its core segment.

Freightos (NASDAQ:CRGO) reported mixed financial and operational metrics for the first quarter of 2026, as geopolitical tensions and airspace restrictions across the Middle East slowed core transaction growth while simultaneously driving up global shipping rates to support the logistics platform's overall transaction value.

Genprex (NASDAQ:GNPX) announced the official abstract publication of positive clinical biomarker data for its lead oncology candidate, Reqorsa gene therapy (quaratusugene ozeplasmid), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.

iQSTEL (NASDAQ:IQST) reported a 69.9% surge in consolidated revenue for the first quarter of 2026, driven by consistent volume expansion across its core telecommunications subsidiaries and an increasingly meaningful operational lift from its newly integrated fintech assets.

Biohaven (NYSE:BHVN) released new clinical and safety data for opakalim, its selective Kv7.2/7.3 potassium channel activator, showing meaningful reductions in seizure frequency and a highly differentiated central nervous system safety profile across generalized and focal forms of epilepsy.

G. Willi-Food International (NASDAQ:WILC) reported an 8.3% increase in sales for the first quarter of 2026, navigating local geopolitical instability through optimized product mix management and favorable foreign exchange tailwinds.

Terra Quantum entered into a definitive business combination agreement with Axiom Intelligence Acquisition Corp 1 (NASDAQ:AXIMU), a special purpose acquisition company, to take the Swiss quantum technology developer public on the Nasdaq Stock Market.

NervGen Pharma (NYSE:NGEN) reported positive results from an independent, blinded biomechanical gait analysis of its Phase 1b/2a CONNECT SCI study, demonstrating that its lead candidate, NVG-291, achieved statistically significant improvements in walking quality among chronic spinal cord injury patients.

Cogent Communications (NASDAQ:CCOI) entered into a definitive purchase and sale agreement to divest a portfolio of 10 data center facilities to global infrastructure investment manager I Squared Capital for $225 million in cash.

Tonix Pharmaceuticals (NASDAQ:TNXP) presented a retrospective U.S. real-world claims analysis at the ISPOR 2026 annual meeting, detailing a heavy economic and clinical burden among adults diagnosed with fibromyalgia.

Modine Manufacturing Company (NYSE:MOD) signed a monumental multi-year Long-Term Capacity Agreement (LTA) with a strategic data center customer, securing more than $4 billion in guaranteed product commitments for its "Airedale by Modine" critical cooling systems.

AutoZone (NYSE:AZO) reported an 8.4% increase in net sales for the fiscal third quarter, driven by steady growth in domestic same-store sales and accelerating commercial accounts, which cushioned the impact of minor supply chain margin pressures.

Champion Homes (NYSE:SKY) entered into a definitive agreement to acquire the retail assets of Homes Direct, securing 11 high-volume sales locations to accelerate its direct-to-consumer distribution strategy across the Western U.S.